{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T15:50:20Z","timestamp":1789573820080,"version":"build-2803163510"},"update-to":[{"DOI":"10.1371\/journal.pmed.1004484","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000}}],"reference-count":36,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T00:00:00Z","timestamp":1744848000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosmedicine.org"],"crossmark-restriction":false},"short-container-title":["PLoS Med"],"abstract":"<jats:sec id=\"sec014\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Endovascular thrombectomy (EVT) is the standard treatment for acute ischemic stroke due to internal carotid artery (ICA) or middle cerebral artery (MCA) M1 occlusion with a small ischemic core. However, the effect of EVT on acute stroke with a large ischemic core remains unclear. This study aimed to evaluate the association of EVT plus medical care versus medical care alone with outcomes in patients with acute stroke and a large ischemic core due to ICA or MCA M1 occlusion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec015\">\n                    <jats:title>Methods and findings<\/jats:title>\n                    <jats:p>\n                      PubMed, the Cochrane Central Register of Controlled Trials, and ClinicalTrials.gov were searched from January 1, 2000 to September 25, 2024. There were no language restrictions. Randomized controlled trials (RCTs) of patients with acute stroke and a large ischemic core that compared EVT plus medical care versus medical care alone were evaluated. We computed the random-effects estimate based on the inverse variance method. Risk ratio (RR) with 95% confidence interval (CI) was used to measure outcomes of EVT plus medical care versus medical care alone. The primary outcome was functional independence, defined as modified Rankin Scale (mRS) of 0\u20132 at 90 days post-stroke; and the lead secondary outcome was reduced disability, defined as ordinal shift of mRS. Safety outcomes were requiring constant care or death (mRS 5\u20136), death, and early symptomatic intracranial hemorrhage (sICH). Grading of Recommendations Assessment, Development and Evaluations (GRADE) was used to evaluate summaries of evidence for the outcomes. We included six RCTs comprising 1870 patients (826 females [44.2%]) with acute stroke and a larger moderate or large ischemic core due to ICA or MCA M1 occlusion. All patients were nondisabled before stroke. Pooled results showed that at 90 days post-stroke, EVT plus medical care, compared with medical care alone, was associated with greater functional independence (RR 2.53, 95% CI [1.95, 3.29];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009 &lt; 0.001; number needed to treat [NNT], 9, 95% CI [6,15]) and reduced disability (common odds ratio 1.63, 95% CI [1.38, 1.93];\n                      <jats:italic>p<\/jats:italic>\n                      &lt; 0.001; NNT, 4 [minimum possible NNT, 2; maximum possible NNT, 6]). EVT plus medical care, compared with medical care alone, was associated with a lower risk of requiring constant care or death (RR 0.74, 95% CI [0.66, 0.84];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt; \u20090.001; NNT, 7, 95% CI [6,11]). EVT plus medical care, compared with medical care alone, was associated with a nonsignificantly higher proportion of patients with early symptomatic intracranial hemorrhage (RR 1.65, 95% CI [1.00, 2.70];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009= \u20090.05). The rates of death were not significantly different between the EVT plus medical care and medical care alone groups (RR 0.86, 95% CI [0.72, 1.02];\n                      <jats:italic>p<\/jats:italic>\n                      \u2009= \u20090.08). Main limitations include variability in imaging definitions of large core and inclusion of both larger moderate and large cores in the analysis.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec id=\"sec016\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Among patients with acute stroke and a larger moderate or large ischemic core due to ICA or MCA M1 occlusion who were nondisabled before stroke, EVT plus medical care, compared with medical care alone, may be associated with improved functional independence, reduced disability, and reduced rates of severe disability or death at 90 days post-stroke.<\/jats:p>\n                    <jats:p>PROSPERO registration number: CRD42024514605<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1371\/journal.pmed.1004484","type":"journal-article","created":{"date-parts":[[2025,4,17]],"date-time":"2025-04-17T13:44:21Z","timestamp":1744897461000},"page":"e1004484","update-policy":"https:\/\/doi.org\/10.1371\/journal.pmed.corrections_policy","source":"Crossref","is-referenced-by-count":13,"title":["Endovascular thrombectomy in acute stroke with a large ischemic core: A systematic review and meta-analysis of randomized controlled trials"],"prefix":"10.1371","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0942-7492","authenticated-orcid":true,"given":"Chun-Hsien","family":"Lin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7491-0571","authenticated-orcid":true,"given":"Meng","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Ovbiagele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5109-8736","authenticated-orcid":true,"given":"David S.","family":"Liebeskind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3117-2046","authenticated-orcid":true,"given":"Borja","family":"Sanz-Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L.","family":"Saver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2025,4,17]]},"reference":[{"key":"pmed.1004484.ref001","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(16)00163-X","article-title":"Endovascular thrombectomy after large-vessel ischaemic stroke: a meta-analysis of individual patient data from five randomised trials","volume":"387","author":"M Goyal","year":"2016","journal-title":"Lancet"},{"key":"pmed.1004484.ref002","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1706442","article-title":"Thrombectomy 6 to 24 hours after stroke with a mismatch between deficit and infarct","volume":"378","author":"RG Nogueira","year":"2018","journal-title":"N Engl J Med"},{"key":"pmed.1004484.ref003","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1056\/NEJMoa1713973","article-title":"Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging","volume":"378","author":"GW Albers","year":"2018","journal-title":"N Engl J Med"},{"issue":"10","key":"pmed.1004484.ref004","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1001\/jamaneurol.2019.2109","article-title":"Outcomes of endovascular thrombectomy vs medical management alone in patients with large ischemic cores: a Secondary Analysis of the Optimizing Patient\u2019s Selection for Endovascular Treatment in Acute Ischemic Stroke (SELECT) Study","volume":"76","author":"A Sarraj","year":"2019","journal-title":"JAMA Neurol"},{"key":"pmed.1004484.ref005","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1056\/NEJMoa2118191","article-title":"Endovascular therapy for acute stroke with a large ischemic region","volume":"386","author":"S Yoshimura","year":"2022","journal-title":"N Engl J Med"},{"key":"pmed.1004484.ref006","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1056\/NEJMoa2213379","article-title":"Trial of endovascular therapy for acute ischemic stroke with large infarct","volume":"388","author":"X Huo","year":"2023","journal-title":"N Engl J Med"},{"issue":"10414","key":"pmed.1004484.ref007","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(23)02032-9","article-title":"Endovascular thrombectomy for acute ischaemic stroke with established large infarct: multicentre, open-label, randomised trial","volume":"402","author":"M Bendszus","year":"2023","journal-title":"Lancet"},{"key":"pmed.1004484.ref008","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1056\/NEJMoa2314063","article-title":"Trial of thrombectomy for stroke with a large infarct of unrestricted size","volume":"390","author":"V Costalat","year":"2024","journal-title":"N Engl J Med"},{"key":"pmed.1004484.ref009","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1056\/NEJMoa2214403","article-title":"Trial of endovascular thrombectomy for large ischemic strokes","volume":"388","author":"A Sarraj","year":"2023","journal-title":"N Engl J Med"},{"key":"pmed.1004484.ref010","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1001\/jama.2024.13933","article-title":"Thrombectomy for stroke with large infarct on noncontrast CT: the TESLA randomized clinical trial","volume":"332","author":"The Writing Committee for the TESLA Investigators","year":"2024","journal-title":"JAMA"},{"key":"pmed.1004484.ref011","author":"JPT Higgins","year":"2024"},{"key":"pmed.1004484.ref012","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"MJ Page","year":"2021","journal-title":"BMJ"},{"key":"pmed.1004484.ref013","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"JAC Sterne","year":"2019","journal-title":"BMJ"},{"issue":"12","key":"pmed.1004484.ref014","doi-asserted-by":"crossref","first-page":"3828","DOI":"10.1161\/STROKEAHA.109.561365","article-title":"Quantifying the value of stroke disability outcomes: WHO global burden of disease project disability weights for each level of the modified Rankin Scale","volume":"40","author":"K-S Hong","year":"2009","journal-title":"Stroke"},{"key":"pmed.1004484.ref015","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.1161\/STROKEAHA.121.034480","article-title":"Standardized nomenclature for modified Rankin Scale global disability outcomes: consensus recommendations from Stroke Therapy Academic Industry Roundtable XI","volume":"52","author":"JL Saver","year":"2021","journal-title":"Stroke"},{"key":"pmed.1004484.ref016","first-page":"16","article-title":"15.4.4.2 Computing risk differences or NNT from a risk ratio.","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions Version 6.5","author":"HJ Sch\u00fcnemann","year":"2024"},{"key":"pmed.1004484.ref017","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1136\/bmj.39343.408449.80","article-title":"Uncertainty in heterogeneity estimates in meta-analyses","volume":"335","author":"JP Ioannidis","year":"2007","journal-title":"BMJ"},{"issue":"6","key":"pmed.1004484.ref018","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1161\/STROKEAHA.108.540708","article-title":"Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale","volume":"40","author":"MG Lansberg","year":"2009","journal-title":"Stroke"},{"key":"pmed.1004484.ref019","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"GH Guyatt","year":"2008","journal-title":"BMJ"},{"key":"pmed.1004484.ref020","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0140-6736(07)60149-4","article-title":"Thrombolysis with alteplase for acute ischaemic stroke in the Safe Implementation of Thrombolysis in Stroke-Monitoring Study (SITS-MOST): an observational study","volume":"369","author":"N Wahlgren","year":"2007","journal-title":"Lancet"},{"key":"pmed.1004484.ref021","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1161\/STROKEAHA.115.010049","article-title":"The Heidelberg Bleeding Classification: classification of bleeding events after ischemic stroke and reperfusion therapy","volume":"46","author":"R von Kummer","year":"2015","journal-title":"Stroke"},{"key":"pmed.1004484.ref022","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1161\/STROKEAHA.121.038153","article-title":"Fragility index meta-analysis of randomized controlled trials shows highly robust evidential strength for benefit of <3 hour intravenous Alteplase","volume":"53","author":"KT Mun","year":"2022","journal-title":"Stroke"},{"key":"pmed.1004484.ref023","doi-asserted-by":"crossref","first-page":"524220","DOI":"10.3389\/fneur.2020.524220","article-title":"The minimal clinically important difference for achievement of substantial reperfusion with endovascular thrombectomy devices in acute ischemic stroke treatment","volume":"11","author":"CJ Lin","year":"2020","journal-title":"Front Neurol"},{"key":"pmed.1004484.ref024","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2024.0572","article-title":"Endovascular thrombectomy for large ischemic stroke across ischemic injury and Penumbra profiles","volume":"331","author":"A Sarraj","year":"2024","journal-title":"JAMA"},{"key":"pmed.1004484.ref025","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S1474-4422(18)30242-4","article-title":"Imaging features and safety and efficacy of endovascular stroke treatment: a meta-analysis of individual patient-level data","volume":"17","author":"LS Roman","year":"2018","journal-title":"Lancet Neurol"},{"key":"pmed.1004484.ref026","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1159\/000492400","article-title":"Regional contributions to Poststroke disability in endovascular therapy","volume":"7","author":"SA Sheth","year":"2018","journal-title":"Interv Neurol"},{"key":"pmed.1004484.ref027","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/neurintsurg-2016-012494","article-title":"Admission CT perfusion may overestimate initial infarct core: the ghost infarct core concept","volume":"9","author":"S Boned","year":"2017","journal-title":"J Neurointerv Surg"},{"key":"pmed.1004484.ref028","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1212\/WNL.0000000000009173","article-title":"Reversible diffusion-weighted imaging lesions in acute ischemic stroke: a systematic review","volume":"94","author":"N Nagaraja","year":"2020","journal-title":"Neurology"},{"key":"pmed.1004484.ref029","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1161\/STROKEAHA.118.024263","article-title":"Ischemic diffusion lesion reversal after endovascular treatment","volume":"50","author":"J Yoo","year":"2019","journal-title":"Stroke"},{"key":"pmed.1004484.ref030","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1161\/STROKEAHA.123.044916","article-title":"Thrombectomy in patients with ischemic stroke without salvageable tissue on CT perfusion","volume":"55","author":"G Broocks","year":"2024","journal-title":"Stroke"},{"issue":"20","key":"pmed.1004484.ref031","doi-asserted-by":"crossref","first-page":"e2043","DOI":"10.1212\/WNL.0000000000207869","article-title":"Endovascular thrombectomy in patients with very low ASPECTS scores: a systematic review and meta-analysis","volume":"101","author":"AH Katsanos","year":"2023","journal-title":"Neurology"},{"key":"pmed.1004484.ref032","doi-asserted-by":"crossref","first-page":"e223320","DOI":"10.1148\/radiol.223320","article-title":"Cost-effectiveness of endovascular treatment for acute stroke with large infarct: a United States perspective","volume":"309","author":"JM Ospel","year":"2023","journal-title":"Radiology"},{"key":"pmed.1004484.ref033","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1136\/jnis-2023-021068","article-title":"Cost-effectiveness of endovascular therapy for acute stroke with a large ischemic region in Japan: impact of the Alberta Stroke Program Early CT Score on cost-effectiveness","volume":"17","author":"S Egashira","year":"2024","journal-title":"J Neurointerv Surg"},{"key":"pmed.1004484.ref034","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1136\/jnis-2023-020411","article-title":"Endovascular therapy in acute ischemic stroke with poor reperfusion is associated with worse outcomes compared with best medical management: a HERMES substudy","volume":"16","author":"N Rex","year":"2024","journal-title":"J Neurointerv Surg"},{"key":"pmed.1004484.ref035","article-title":"Endovascular thrombectomy for large ischemic strokes: meta-analysis of six multicenter randomized controlled trials","author":"H Chen","year":"2024","journal-title":"J Neurointerv Surg"},{"issue":"1","key":"pmed.1004484.ref036","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/17474930231191033","article-title":"Evaluation of acute mechanical revascularization in large stroke (ASPECTS \u2a7d 5) and large vessel occlusion within 7\u2009h of last-seen-well: the LASTE multicenter, randomized, clinical trial protocol","volume":"19","author":"V Costalat","year":"2024","journal-title":"Int J Stroke"}],"updated-by":[{"DOI":"10.1371\/journal.pmed.1004484","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T00:00:00Z","timestamp":1745798400000}}],"container-title":["PLOS Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,12]],"date-time":"2025-05-12T11:18:39Z","timestamp":1747048719000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pmed.1004484"}},"subtitle":[],"editor":[{"given":"Iris","family":"Grunwald","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2025,4,17]]},"references-count":36,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4,17]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pmed.1004484","relation":{},"ISSN":["1549-1676"],"issn-type":[{"value":"1549-1676","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,17]]}}}